Fig. 6From: The impact of the private sector co-payment mechanism (PSCM) on the private market for ACT in Nigeria: results of the 2018 cross-sectional outlet and household market surveysDrug brands purchased by each HH. No HHs reported purchasing: Arsumax, Artemef, Artequick, ASAQ, Colart, Diasunate, DrutemalPlus, Dupridox, GSunate, Havax, Lariact, Larimal, Malagold, Moko, Nimartem, Pamametre, Q300, Reludrine, Tamether, VitadarBack to article page